Improvement in motor symptoms, physical fatigue, and self-rated change perception in functional motor disorders: a prospective cohort study of a 12-week telemedicine program.
Anxiety
Depression
Gait disorders
Motor symptoms
Physical fatigue
Quality of life
Telemedicine
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
12
05
2022
accepted:
13
06
2022
revised:
13
06
2022
pubmed:
10
7
2022
medline:
14
10
2022
entrez:
9
7
2022
Statut:
ppublish
Résumé
Functional motor disorders (FMDs) are highly disabling conditions associated with long-term disability, poor quality of life, and economic burden on health and social care. While multidisciplinary 5-days rehabilitation programs have been shown to reduce motor and non-motor symptoms, long-term management and monitoring in FMDs remain an unmet need. To compare a 12-weeks telemedicine program against a 12-weeks self-management program after a 5-days rehabilitation program for improving motor, non-motor symptoms, quality of life, and perception of change in patients with FMDs. The study population was 64 consecutive patients with a definite diagnosis of FMDs who underwent a 5-days in-person rehabilitation program followed by either a self-management (the first 32 patients) or a telemedicine program (the latter 32 patients). Validated measures of motor and non-motor symptoms such as fatigue and pain, quality of life, perception of change, gait, and postural control were recorded before (T0), after completion of rehabilitation (T1), and then again at 3 months (T2). Improvement at 3-month follow-up assessment of motor symptoms (p < 0.001), physical fatigue (p = 0.028), and self-rated change perception (p = 0.043) was greater in the telemedicine group. No different between-groups effect was found on other dimensions of fatigue, pain, physical and mental health, and gait and postural control. Long-term management and expert monitoring of patients with FMDs via telemedicine may enhance long-term outcomes in motor symptoms and physical fatigue, with a positive long-term impact on self-rated health perception of change.
Sections du résumé
BACKGROUND
BACKGROUND
Functional motor disorders (FMDs) are highly disabling conditions associated with long-term disability, poor quality of life, and economic burden on health and social care. While multidisciplinary 5-days rehabilitation programs have been shown to reduce motor and non-motor symptoms, long-term management and monitoring in FMDs remain an unmet need.
AIM
OBJECTIVE
To compare a 12-weeks telemedicine program against a 12-weeks self-management program after a 5-days rehabilitation program for improving motor, non-motor symptoms, quality of life, and perception of change in patients with FMDs.
METHODS
METHODS
The study population was 64 consecutive patients with a definite diagnosis of FMDs who underwent a 5-days in-person rehabilitation program followed by either a self-management (the first 32 patients) or a telemedicine program (the latter 32 patients). Validated measures of motor and non-motor symptoms such as fatigue and pain, quality of life, perception of change, gait, and postural control were recorded before (T0), after completion of rehabilitation (T1), and then again at 3 months (T2).
RESULTS
RESULTS
Improvement at 3-month follow-up assessment of motor symptoms (p < 0.001), physical fatigue (p = 0.028), and self-rated change perception (p = 0.043) was greater in the telemedicine group. No different between-groups effect was found on other dimensions of fatigue, pain, physical and mental health, and gait and postural control.
CONCLUSIONS
CONCLUSIONS
Long-term management and expert monitoring of patients with FMDs via telemedicine may enhance long-term outcomes in motor symptoms and physical fatigue, with a positive long-term impact on self-rated health perception of change.
Identifiants
pubmed: 35809125
doi: 10.1007/s00415-022-11230-8
pii: 10.1007/s00415-022-11230-8
pmc: PMC9552134
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5940-5953Informations de copyright
© 2022. The Author(s).
Références
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1113-9
pubmed: 25433033
Epilepsia. 2020 Nov;61(11):2572-2582
pubmed: 33015831
Neurol Clin Pract. 2016 Apr;6(2):138-149
pubmed: 27104066
Brain. 2017 Aug 1;140(8):2240-2245
pubmed: 28899013
Parkinsonism Relat Disord. 2020 Jul;76:108-111
pubmed: 31078400
Biomed Res Int. 2017;2017:7962826
pubmed: 29333454
JAMA Neurol. 2018 Sep 1;75(9):1132-1141
pubmed: 29868890
J Neurol Neurosurg Psychiatry. 2021 Mar 15;:
pubmed: 33722822
Front Hum Neurosci. 2017 Jun 06;11:291
pubmed: 28634447
NeuroRehabilitation. 2022;50(2):245-254
pubmed: 35213333
Lancet Neurol. 2012 Mar;11(3):250-60
pubmed: 22341033
J Neurol. 2018 Aug;265(8):1803-1809
pubmed: 29860667
J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):638-649
pubmed: 32111637
Neuropsychiatr Dis Treat. 2020 Sep 18;16:2119-2134
pubmed: 32982250
Mov Disord Clin Pract. 2020 Sep 22;7(8):920-929
pubmed: 33163563
CNS Spectr. 2020 Sep 04;:1-7
pubmed: 32883381
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Curr Treat Options Neurol. 2014 Apr;16(4):286
pubmed: 24566832
J Telemed Telecare. 2018 Sep;24(8):511-526
pubmed: 28696152
Handb Clin Neurol. 2017;139:47-60
pubmed: 27719864
Disabil Rehabil. 2020 Jul;42(14):2043-2048
pubmed: 30669889
Clin Park Relat Disord. 2022 Mar 01;6:100139
pubmed: 35252835
Brain. 2012 Jan;135(Pt 1):117-23
pubmed: 22075068
J Psychosom Res. 2019 Jan;116:10-16
pubmed: 30654984
Parkinsonism Relat Disord. 2012 Mar;18(3):247-51
pubmed: 22113131
Can J Neurol Sci. 2021 Mar;48(2):204-217
pubmed: 32690119
Front Neurol. 2021 Dec 08;12:786126
pubmed: 34956066
J Neurol. 2021 Dec;268(12):4737-4743
pubmed: 33961091
J Neurol. 2015 Mar;262(3):674-81
pubmed: 25557282
Parkinsonism Relat Disord. 2015 May;21(5):529-32
pubmed: 25772324
NeuroRehabilitation. 2021;48(3):305-314
pubmed: 33780378
Curr Opin Neurol. 2013 Aug;26(4):442-7
pubmed: 23823467
Handb Clin Neurol. 2017;139:131-137
pubmed: 27719834
Curr Opin Neurol. 2009 Aug;22(4):430-6
pubmed: 19542886
Lancet Neurol. 2017 Jul;16(7):541-551
pubmed: 28566190
J Psychosom Res. 2018 Dec;115:32-37
pubmed: 30470314
J Psychosom Res. 1996 Dec;41(6):551-9
pubmed: 9032718
Neurol Clin Pract. 2017 Apr;7(2):141-147
pubmed: 29185540
Eur J Neurol. 2021 May;28(5):1752-1758
pubmed: 33300269
Pain. 1996 Apr;65(1):87-92
pubmed: 8826494
J Psychosom Res. 1995 Apr;39(3):315-25
pubmed: 7636775
Br J Sports Med. 2021 Feb;55(3):155-162
pubmed: 33060156
Eur J Neurol. 2021 Dec;28(12):3921-3924
pubmed: 34478601
Parkinsonism Relat Disord. 2021 Dec;93:40-42
pubmed: 34784525
J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):484-490
pubmed: 27694498
Physiotherapy. 2017 Jun;103(2):180-185
pubmed: 27913064
Neurol Clin Pract. 2021 Oct;11(5):e686-e690
pubmed: 34840884
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):810-3
pubmed: 21257981
J Neuropsychiatry Clin Neurosci. 2016 Summer;28(3):168-90
pubmed: 26900733
J Neurol. 2020 Jul;267(7):2164-2172
pubmed: 32193596
NeuroRehabilitation. 2022;50(2):231-243
pubmed: 35213332
Brain. 2012 Nov;135(Pt 11):3495-512
pubmed: 22641838
JMIR Rehabil Assist Technol. 2017 Jul 21;4(2):e7
pubmed: 28733271
Curr Opin Neurol. 2017 Aug;30(4):427-434
pubmed: 28590986